Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001999371-24-014569
Filing Date
2024-11-12
Accepted
2024-11-12 17:10:36
Documents
98
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_093024.htm   iXBRL 10-Q 1553507
2 SECTION 302 CERTIFICATION ex31-01.htm EX-31.01 12441
3 SECTION 302 CERTIFICATION ex31-02.htm EX-31.02 12287
4 SECTION 906 CERTIFICATION ex32-01.htm EX-32.01 5026
5 SECTION 906 CERTIFICATION ex32-02.htm EX-32.02 4909
  Complete submission text file 0001999371-24-014569.txt   8567763

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tnxp-20240930.xsd EX-101.SCH 71445
7 XBRL CALCULATION FILE tnxp-20240930_cal.xml EX-101.CAL 86717
8 XBRL DEFINITION FILE tnxp-20240930_def.xml EX-101.DEF 290885
9 XBRL LABEL FILE tnxp-20240930_lab.xml EX-101.LAB 545653
10 XBRL PRESENTATION FILE tnxp-20240930_pre.xml EX-101.PRE 445285
101 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-10q_093024_htm.xml XML 1307421
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 241449787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)